Results 161 to 170 of about 1,944,029 (193)
Some of the next articles are maybe not open access.

Prediction of Atropisomerism for Drug-like Molecules

Journal of Chemical Information and Modeling
A multistep computational workflow that accurately assigns organic drug-like molecules to one of three atropisomer classes on the basis of computed barrier heights has been developed. The workflow identifies rotatable bonds and applies progressively more accurate types of calculations to the eligible rotational degrees of freedom.
Ty Balduf   +7 more
openaire   +2 more sources

How drug-like are ‘ugly’ drugs: do drug-likeness metrics predict ADME behaviour in humans?

Drug Discovery Today, 2014
Using a published drug-likeness score based on the calculated physicochemical properties of marketed oral drugs (quantitative estimate of drug-likeness, QED) and published human data, high-scoring and low-scoring drugs were compared to determine how well the score correlated with their actual pharmaceutical and pharmacokinetic (PK) profiles in humans ...
Timothy J, Ritchie, Simon J F, Macdonald
openaire   +2 more sources

TRPs: Modulation by Drug-Like Compounds

2014
Drug-like compounds that exert biological activity towards TRP channels are either being used as cell biological tools or further developed into pharmacological lead structures aiming at therapeutic use in diseased states. Although drug-likeliness is not easy to predict, common rules include a relatively low molecular weight, physicochemical ...
openaire   +2 more sources

Drug-Like Property Concepts in Pharmaceutical Design

Current Pharmaceutical Design, 2009
The pharmaceutical industry is facing an ever increasing challenge to deliver safer and more effective medicines. Traditionally, drug discovery programs were driven solely by potency, regardless of the properties. As a result, the development of non-drug-like molecules was costly, had high risk and low success rate.
Li, Di, Edward H, Kerns, Guy T, Carter
openaire   +2 more sources

Skin Occlusion: Treatment or Drug-Like Device?

Skin Pharmacology, 2009
The effects of occlusion on skin function are described and reviewed. Occlusion seems to be not only a device applied on the skin surface, but, under certain conditions, a powerful treatment capable of inducing several changes on epidermal metabolism, skin flora, sweat glands and epidermal morphology.
E, Berardesca, H I, Maibach
openaire   +2 more sources

Lipid‐Bilayer Permeation of Drug‐Like Compounds

Chemistry & Biodiversity, 2009
AbstractLipid‐bilayer permeation is determinant for the disposition of xenobiotics in the body. It controls the pharmacokinetic behavior of drugs and is, in many cases, a prerequisite for intracellular targeting. Permeation ofin vivobarriers is in general predicted from lipophilicity and related parameters.
Stefanie D, Krämer   +4 more
openaire   +2 more sources

ChemInform Abstract: Drug‐Like Index: A New Approach to Measure Drug‐Like Compounds and Their Diversity.

ChemInform, 2001
AbstractChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable via the “References” option.
Jun Xu, James Stevenson
openaire   +1 more source

STEROIDAL THIOSEMICARBAZONES: DRUG-LIKENESS AND ANTIOXIDANT PROPERTIES

XXX Savetovanje o biotehnologiji sa međunarodnim učešćem
Thiosemicarbazones (TSCs) are well known for their diverse biological activities and wide-ranging applications. This study assessed the drug- likeness and antioxidant potential of previously synthesized steroidal TSCs with promising cytotoxicity. While all tested androstane TSCs are drug-like, they have poor water solubility, strong plasma protein ...
Živković, Marijana   +4 more
openaire   +2 more sources

Antibody–Drug Conjugates: Smart Chemotherapy Delivery Across Tumor Histologies

Ca-A Cancer Journal for Clinicians, 2022
Shanu Modi   +2 more
exaly  

Two antiretroviral drugs likely to be confused

American Journal of Health-System Pharmacy, 1998
J T, Johnson, E B, Dunn, J J, Wolfe
openaire   +2 more sources

Home - About - Disclaimer - Privacy